Polyamines and hair: a couple in search of perfection

Experimental Dermatology

Volumn 19, Issue 9, 2010, Pages 784-790

  Ramot, Yuval ^a   Pietilä, Marko ^b   Giuliani, Giammaria ^c   Rinaldi, Fabio ^d   Alhonen, Leena ^b   Paus, Ralf ^e,f  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c GIULIANI S P A   (Italy)

^d International Hair Research Foundation   (Italy)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Eflornithine; Hair; Ornithine decarboxylase; Polyamines; Spermidine

Indexed keywords

ORNITHINE DECARBOXYLASE; POLYAMINE;

ARTICLE; CARCINOGENESIS; DARIER DISEASE; ENZYME ACTIVITY; HAIR; HAIR FOLLICLE; HAIR GROWTH; HIRSUTISM; HUMAN; NONHUMAN; POLYAMINE SYNTHESIS; PROTEIN EXPRESSION; SCALP HAIR;

ANIMALS; EFLORNITHINE; HAIR FOLLICLE; HUMANS; ORNITHINE DECARBOXYLASE; POLYAMINES; SKIN NEOPLASMS;

EID: 77955730179     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01111.x     Document Type: Article

References (82)

1. Probst E, Krebs A. Ornithine decarboxylase activity in relation to DNA synthesis in mouse interfollicular epidermis and hair follicles. Biochim Biophys Acta 1975, 407:147-157.
2. Hattori M, Ogawa H. Biochemical analysis of hair growth from the aspects of aging and enzyme activities. J Dermatol 1983, 10:45-54.
3. Lesiewicz J, Morrison D M, Goldsmith L A. Ornithine decarboxylase in rat skin: 2 Differential response to hair plucking and a tumor promoter. J Invest Dermatol 1980, 75:411-416.
4. Blume-Peytavi U, Hahn S. Medical treatment of hirsutism. Dermatol Ther 2008, 21:329-339.
5. Cohen S. A Guide to the Polyamines 1998, New York, N.Y., Oxford University Press
6. Lowe N J. Epidermal ornithine decarboxylase, polyamines, cell proliferation, and tumor promotion. Arch Dermatol 1980, 116:822-825.
7. Persson L. Polyamine homoeostasis. Essays Biochem 2009, 46:11-24.
8. Pegg A E, McCann P P. Polyamine metabolism and function. Am J Physiol 1982, 243:C212-C221.
9. Gerner E W, Meyskens F L. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004, 4:781-792.
10. Pegg A E. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986, 234:249-262.
11. Alm K, Oredsson S. Cells and polyamines do it cyclically. Essays Biochem 2009, 46:63-76.
12. Iwata S, Sato Y, Asada M. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene 1999, 18:165-172.
13. Smith S R, Piacquadio D J, Beger B, Littler C. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg 2006, 32:1237-1243.
14. Pietila M, Pirinen E, Keskitalo S. Disturbed keratinocyte differentiation in transgenic mice and organotypic keratinocyte cultures as a result of spermidine/spermine N-acetyltransferase overexpression. J Invest Dermatol 2005, 124:596-601.
15. Bardócz S, Grant G, Brown D, Ralf A, Pustzai A. Polyamines in food - implications for growth and health. J Nutr Biochem 1993, 4:66-71.
16. Farriol M, Segovia T, Venereo Y, Orta X. Importance of the polyamines: review of the literature. Nutr Hosp 1999, 14:101-113.
17. Auvinen M, Paasinen A, Andersson L C, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992, 360:355-358.
18. Kahana C. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. Essays Biochem 2009, 46:47-61.
19. Gruendler C, Lin Y, Farley J, Wang T. Proteasomal degradation of Smad1 induced by bone morphogenetic proteins. J Biol Chem 2001, 276:46533-46543.
20. Lin Y, Martin J, Gruendler C. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). BMC Cell Biol 2002, 3:15.
21. Newman R M, Mobascher A, Mangold U. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem 2004, 279:41504-41511.
22. Lim S K, Gopalan G. Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A. Oncogene 2007, 26:6593-6603.
23. Stenn K S, Paus R. Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494.
24. Schneider M R, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol 2009, 19:R132-R142.
25. Paus R. Principles of hair cycle control. J Dermatol 1998, 25:793-802.
26. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999, 341:491-497.
27. Stenn K S, Paus R. What controls hair follicle cycling? Exp Dermatol 1999, 8:229-233.
28. Hynd P I, Nancarrow M J. Inhibition of polyamine synthesis alters hair follicle function and fiber composition. J Invest Dermatol 1996, 106:249-253.
29. Sundberg J P, Erickson A A, Roop D R, Binder R L. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10. Cancer Res 1994, 54:1344-1351.
30. Nancarrow M J, Nesci A, Hynd P I, Powell B C. Dynamic expression of ornithine decarboxylase in hair growth. Mech Dev 1999, 84:161-164.
31. Nancarrow M J, Powell B C, Hynd P I. Expression of ornithine decarboxylase during embryonic development of wool follicles. Exp Dermatol 1999, 8:326-328.
32. Shantz L M, Pegg A E. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int J Biochem Cell Biol 1999, 31:107-122.
33. Pi L, Ji J, Oh Y, Kim Y, Hwang S, Lee W. Role of ornithine decarboxylase in human hair follicles. Int J Trichol 2009, 1:65. Poster abstract P18
34. Hickok N J, Wahlfors J, Crozat A. Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogene. Gene 1990, 93:257-263.
35. Slominski A, Zbytek B, Zmijewski M. Corticotropin releasing hormone and the skin. Front Biosci 2006, 11:2230-2248.
36. Wang X, Pasolli H A, Williams T, Fuchs E. AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J Cell Biol 2008, 183:37-48.
37. Janne J, Alhonen L, Pietila M, Keinanen T A. Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem 2004, 271:877-894.
38. Pietila M, Parkkinen J J, Alhonen L, Janne J. Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase. J Invest Dermatol 2001, 116:801-805.
39. Soler A P, Gilliard G, Megosh L C, O'Brien T G. Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J Invest Dermatol 1996, 106:1108-1113.
40. Feith D J, Shantz L M, Pegg A E. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res 2001, 61:6073-6081.
41. Feith D J, Shantz L M, Shoop P L, Keefer K A, Prakashagowda C, Pegg A E. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds. Mol Carcinog 2007, 46:453-465.
42. Wang X, Ikeguchi Y, McCloskey D E, Nelson P, Pegg A E. Spermine synthesis is required for normal viability, growth, and fertility in the mouse. J Biol Chem 2004, 279:51370-51375.
43. Pietila M, Alhonen L, Halmekyto M, Kanter P, Janne J, Porter C W. Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase. J Biol Chem 1997, 272:18746-18751.
44. Ha H C, Woster P M, Yager J D, Casero R A. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci USA 1997, 94:11557-11562.
45. Takigawa M, Verma A K, Simsiman R C, Boutwell R K. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Cancer Res 1983, 43:3732-3738.
46. Crowell J A, Goldenthal E I, Kelloff G J, Malone W F, Boone C W. Chronic toxicity studies of the potential cancer preventive 2-(difluoromethyl)-dl-ornithine. Fundam Appl Toxicol 1994, 22:341-354.
47. Wheeler D L, Ness K J, Oberley T D, Verma A K. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. Cancer Res 2003, 63:3037-3042.
48. Liu S, Murray A, Schlink C, Mata G, Masters D. The effects of intradermal injections of spermidine on the growth rate of fibres and mitosis of wool follicles in Merino lambs. Anim Sci 2002, 75:33-40.
49. Fashe T, Keinänen T, Grigorenko N. Cutaneous application of α-Methylspermidine activates the growth of resting hair follicles in mice. Amino Acids 2010, 38:583-590.
50. Kloepper J E, Sugawara K, Al-Nuaimi Y, Gaspar E, van Beek N, Paus R. Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture. Exp Dermatol 2010, 19:305-310.
51. Matheson H B, Westgate G E, Parmar P P, Riches C, Blount M A, Ellory J C. Nutrition and metabolism in isolated human hair follicles. Exp Dermatol 1999, 8:319-320.
52. de Jonge W J, Hallemeesch M M, Kwikkers K L. Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development. Am J Clin Nutr 2002, 76:128-140.
53. Luk G D, Casero R A. Polyamines in normal and cancer cells. Adv Enzyme Regul 1987, 26:91-105.
54. Megosh L, Gilmour S K, Rosson D. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res 1995, 55:4205-4209.
55. Peralta Soler A, Gilliard G, Megosh L, George K, O'Brien T G. Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res 1998, 58:1654-1659.
56. Guo Y, Zhao J, Sawicki J, Peralta Soler A, O'Brien T G. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression. Mol Carcinog 1999, 26:32-36.
57. Feith D J, Bol D K, Carboni J M. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis. Cancer Res 2005, 65:572-578.
58. Coleman C S, Pegg A E, Megosh L C, Guo Y, Sawicki J A, O'Brien T G. Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis 2002, 23:359-364.
59. Wang X, Feith D J, Welsh P. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis. Carcinogenesis 2007, 28:2404-2411.
60. Pegg A E, Feith D J, Fong L Y, Coleman C S, O'Brien T G, Shantz L M. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem Soc Trans 2003, 31:356-360.
61. Bailey H H, Kim K, Verma A K. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila Pa) 2010, 3:35-47.
62. Metcalf B, Bey P, Danzin C, Jung M, Casara P, Vevert J. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J Am Chem Soc 1978, 100:2551-2553.
63. Wallace H M, Fraser A V. Polyamine analogues as anticancer drugs. Biochem Soc Trans 2003, 31:393-396.
64. Pepin J, Milord F, Guern C, Schechter P J. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness. Lancet 1987, 2:1431-1433.
65. Gimelli G, Giglio S, Zuffardi O. Gene dosage of the spermidine/spermine N(1)-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum Genet 2002, 111:235-241.
66. Tjalve H, Nilsson M, Henningsson A C, Henningsson S. Affinity of putrescine, spermidine and spermine for pigmented tissues. Biochem Biophys Res Commun 1982, 109:1116-1122.
67. Kapyaho K, Janne J. Stimulation of melanotic expression in murine melanoma cells exposed to polyamine antimetabolites. Biochem Biophys Res Commun 1983, 113:18-23.
68. Kapyaho K, Sinervirta R, Janne J. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells. Cancer Res 1985, 45:1444-1448.
69. Bodo E, Tobin D J, Kamenisch Y. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol 2007, 171:1153-1167.
70. Nilsson J, Gritli-Linde A, Heby O. Skin fibroblasts from spermine synthase-deficient hemizygous gyro male (Gy/Y) mice overproduce spermidine and exhibit increased resistance to oxidative stress but decreased resistance to UV irradiation. Biochem J 2000, 352:381-387. Pt 2
71. Ballas S K, Mohandas N, Marton L J, Shohet S B. Stabilization of erythrocyte membranes by polyamines. Proc Natl Acad Sci USA 1983, 80:1942-1946.
72. Johnson D A, Fields C, Fallon A, Fitzgerald M E, Viar M J, Johnson L R. Polyamine-dependent migration of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2002, 43:1228-1233.
73. Gilmour S K. Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 2007, 224:249-256.
74. Ryan J L, Bondy P K, Gobran L, Canellakis Z N. Acetylated diamines inhibit endotoxin-induced lymphocyte activation. J Immunol 1984, 132:1888-1891.
75. Oredsson S M. Polyamine dependence of normal cell-cycle progression. Biochem Soc Trans 2003, 31:366-370.
76. Canellakis Z N, Marsh L L, Bondy P K. Polyamines and their derivatives as modulators in growth and differentiation. Yale J Biol Med 1989, 62:481-491.
77. Suppola S, Pietila M, Parkkinen J J. Overexpression of spermidine/spermine N1-acetyltransferase under the control of mouse metallothionein I promoter in transgenic mice: evidence for a striking post-transcriptional regulation of transgene expression by a polyamine analogue. Biochem J 1999, 338:311-316. Pt 2
78. Panteleyev A A, Christiano A M, O'Brien T G, Sundberg J P. Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions. Exp Dermatol 2000, 9:146-151.
79. Smith M K, Trempus C S, Gilmour S K. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 1998, 19:1409-1415.
80. Wolf J E, Shander D, Huber F. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 2007, 46:94-98.
81. Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007, 57:54-59.
82. Hoffmann R. A 4-month, open-label study evaluating the efficacy of eflornithine 11.5% cream in the treatment of unwanted facial hair in women using TrichoScan. Eur J Dermatol 2008, 18:65-70.